Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Mind Medicine Inc (NASDAQ: MNMD) closed at $6.84 in the last session, down -10.35% from day before closing price of $7.63. In other words, the price has decreased by -$10.35 from its previous closing price. On the day, 1.79 million shares were traded. MNMD stock price reached its highest trading level at $7.8699 during the session, while it also had its lowest trading level at $6.59.
Ratios:
We take a closer look at MNMD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.00 and its Current Ratio is at 9.00. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on December 20, 2024, initiated with a Buy rating and assigned the stock a target price of $20.
On July 24, 2024, ROTH MKM started tracking the stock assigning a Buy rating and target price of $36.ROTH MKM initiated its Buy rating on July 24, 2024, with a $36 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 26 ’24 when Barrow Robert sold 19,106 shares for $7.43 per share. The transaction valued at 141,958 led to the insider holds 526,666 shares of the business.
Liao Carrie sold 2,273 shares of MNMD for $16,888 on Dec 26 ’24. The Chief Accounting Officer now owns 97,270 shares after completing the transaction at $7.43 per share. On Dec 26 ’24, another insider, Karlin Dan, who serves as the Chief Medical Officer of the company, sold 6,643 shares for $7.43 each. As a result, the insider received 49,357 and left with 338,013 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 501588800 and an Enterprise Value of 230615760.
Stock Price History:
Over the past 52 weeks, MNMD has reached a high of $12.22, while it has fallen to a 52-week low of $3.49. The 50-Day Moving Average of the stock is -4.96%, while the 200-Day Moving Average is calculated to be -10.49%.
Shares Statistics:
According to the various share statistics, MNMD traded on average about 1.19M shares per day over the past 3-months and 1246130 shares per day over the past 10 days. A total of 81.59M shares are outstanding, with a floating share count of 27.25M. Shares short for MNMD as of 1734048000 were 9443063 with a Short Ratio of 7.94, compared to 1731628800 on 10054736. Therefore, it implies a Short% of Shares Outstanding of 9443063 and a Short% of Float of 12.889999999999999.
